There are 238 papers on chronic heart failure in aging research: 36 trials and 130 observational studies in people, 6 in animals, 55 reviews.
238 papers study it293 more mention it49 findings
39 new papers in 30 daysSee all 531 papers on chronic heart failure
At a glance
Chronic heart failure is linked with frailty and sarcopenia in human studies, slower gait in geriatric ward patients, and higher dementia risk. Human studies associate it with higher mortality after acute coronary syndrome discharge, but a study of critically ill COVID-19 patients shows no clear mortality link after adjustment for SOFA, age, sex and frailty.
49 findings in 36 papers from 2003 to 2026, 4 of them since May 2026
“Diabetes, stroke, HF and AF were significantly associated with dementia risk, hazard ratios ranged from 1.08 to 3.54.”
- Human trial36
- Humans130
- Animals6
- In silico1
Interventions
2Isoproterenol
upin rats1
1 study
Isoproterenol
upin rats1
Isoproterenol induces chronic heart failure in rats.
Animals10 mg/kg, four injections60 daysmales
NAD+
downin reviews1
1 study
NAD+
downin reviews1
NAD+ decreases chronic heart failure (via mitochondrial redox state mechanism).
Reviewvia mitochondrial redox state mechanismheart
Effects
8CC16
upin humans1
1 study
CC16
upin humans1
Chronic heart failure is linked with higher CC16 in humans (adjusted linear regression) (est. = 4.69 (1.37; 8.02)).
Humansadjusted linear regressionbetween 2011 and 2014n = 497
Chronic heart failure is linked with higher CC16 in humans (est. 4.69 [1.37; 8.02], p = 5.91 × 10−3).
Humans
Mortality
no changein humans1
1 study
Mortality
no changein humans1
Chronic heart failure was not clearly linked with mortality in humans (critically ill COVID-19 patients after adjustment for SOFA, age, sex, and frailty) (aOR 1.2, 95% CI 0.5-1.5, P = 0.137).
Humanscritically ill COVID-19 patients after adjustment for SOFA, age, sex, and frailtyn = 3,917
MIR21
upin humans1
1 study
MIR21
upin humans1
Chronic heart failure is linked with higher MIR21 in humans (chronic heart failure).
Humanschronic heart failuremales
Hand grip strength
downin humans1
1 study
Hand grip strength
downin humans1
Chronic heart failure is linked with worse hand grip strength in patients with chronic heart failure compared to healthy controls.
Humansin patients with chronic heart failure compared to healthy controlsmales
Hindlimb blood flow
downin rats1
1 study
Hindlimb blood flow
downin rats1
Chronic heart failure decreases hindlimb blood flow in rats during submaximal exercise (111±10 vs 133±12 mL/min/100g).
Animalsduring submaximal exercisehindlimb muscle
Diaphragm blood flow
upin rats1
1 study
Diaphragm blood flow
upin rats1
Chronic heart failure increases diaphragm blood flow in rats during submaximal exercise (257±32 vs 121±9 mL/min/100g).
Animalsduring submaximal exercisediaphragm
Inspiratory function
downin reviews1
1 study
Inspiratory function
downin reviews1
Chronic heart failure impairs inspiratory function (aging).
Reviewagingdiaphragm
Daily physical activity level
downin humans1
1 study
Daily physical activity level
downin humans1
Chronic heart failure is linked with lower daily physical activity level in patients with CHF and patients with COPD.
Humansin patients with CHF and patients with COPD
Upstream
1Body mass index
no changein humans1HR 1.08
1 study
Body mass index
no changein humans1HR 1.08
Body mass index was not clearly linked with chronic heart failure in humans (adjusted for age, race, sex, site, education, smoking, COPD, and waist circumference) (HR 1.08, 95% CI 0.86-1.35).
Humansadjusted for age, race, sex, site, education, smoking, COPD, and waist circumference6.1+/-1.4 yearsn = 2,435
Associations
27Sarcopenia
upin humans5upin reviews1OR 6.1
6 studies
Sarcopenia
upin humans5upin reviews1OR 6.1
Chronic heart failure is associated with sarcopenia in humans (Adjusted association) (Adjusted OR 6.1, 95% CI 2.70–13.73).
HumansAdjusted associationn = 140
Chronic heart failure is associated with sarcopenia in geriatric ward patients (40.4% vs. 29%, p = 0.046).
Humansin geriatric ward patientsn = 416
Chronic heart failure is associated with sarcopenia in humans (multivariable Cox regression) (PR 1.31, 95% CI 1.02-1.68).
Humansmultivariable Cox regressionn = 588
Sarcopenia is associated with chronic heart failure in patients with cardiovascular disease.
Humansin patients with cardiovascular disease
Chronic heart failure is associated with sarcopenia in CHF patients.
Reviewin CHF patients
Chronic heart failure is associated with sarcopenia.
Review
Frailty
upin humans4
4 studies
Frailty
upin humans4
Chronic heart failure is linked with a higher risk of frailty in humans (multimorbidity) (β = 0.788).
Humansmultimorbidityn = 3,836
Chronic heart failure is associated with frailty in humans (compared with control patients, across six frailty tools) (30% to 52% vs. 2% to 15%).
Humanscompared with control patients, across six frailty tools
Chronic heart failure is associated with frailty in patients with chronic heart failure (39% (95% CI: 0.33-0.45)).
Reviewin patients with chronic heart failuren = 6,287
Chronic heart failure is associated with frailty in older patients with chronic heart failure (38% (95%CI: 0.32-0.44)).
Reviewin older patients with chronic heart failuren = 4,797
Mortality
upin humans2OR 1.87
2 studies
Mortality
upin humans2OR 1.87
Chronic heart failure predicts mortality in humans after acute coronary syndrome discharge (sHR 1.99, 95% CI 1.96–2.02).
Humansafter acute coronary syndrome discharge
Chronic heart failure is linked with a higher risk of mortality in humans (critically ill COVID-19 patients in intensive care) (OR 1.87, 95% CI 1.5-2.3, P < 0.001).
Humanscritically ill COVID-19 patients in intensive caren = 3,917
Senescence-related hub genes
mixedin humans1mixedin rats1
1 study
Senescence-related hub genes
mixedin humans1mixedin rats1
senescence-related hub genes are associated with chronic heart failure in humans.
Humans
senescence-related hub genes are associated with chronic heart failure in rats (doxorubicin-induced CHF model).
Animalsdoxorubicin-induced CHF model
Presence of at least one cardiovascular-renal-hepatic-metabolic syndrome component
upin humans1
1 study
Presence of at least one cardiovascular-renal-hepatic-metabolic syndrome component
upin humans1
Chronic heart failure is associated with presence of at least one cardiovascular-renal-hepatic-metabolic syndrome component in humans (Hospitalized for chronic heart failure decompensation) (88.5% (n=370)).
HumansHospitalized for chronic heart failure decompensationn = 418
Cognitive frailty
upin humans1
1 study
Cognitive frailty
upin humans1
Chronic heart failure is associated with cognitive frailty in humans (patients with chronic heart failure) (39.3% (95% CI: 31.0%-47.7%)).
Reviewpatients with chronic heart failure
Inflammatory biomarkers
upin humans1
1 study
Inflammatory biomarkers
upin humans1
Chronic heart failure is associated with inflammatory biomarkers in humans.
Review
Corynebacterium
downin humans1
1 study
Corynebacterium
downin humans1
Corynebacterium is linked with a lower risk of chronic heart failure in humans.
Humans
Endothelial dysfunction
upin humans1
1 study
Endothelial dysfunction
upin humans1
Endothelial dysfunction raises the risk of chronic heart failure in CHF.
Reviewin CHF
Senescence-related hub gene diagnostic model
upin silico1
1 study
Senescence-related hub gene diagnostic model
upin silico1
Senescence-related hub gene diagnostic model predicts chronic heart failure in silico (AUC exceeding 0.7).
In silico
All 27Fewer
Trial sponsors
Company4 trialsPhase 4969 people
Company1 trialPhase 4100 people
Company1 trialPhase 470 people
Company1 trialPhase 4
Novartis Pharmaceuticals Corporation
Company3 trialsPhase 37,963 people
Company1 trialPhase 31,900 people
Company1 trialPhase 3565 people
Cardiovascular Clinical Sciences
Company1 trialPhase 3400 people
Funding
13 grants since 2016National Heart, Lung, and Blood Institute$7.1MJapan Society for the Promotion of Science¥25MJapan Society for the Promotion of Science
Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure
European CommissionStichting Netherlands Heart Institute€5.9M2023–2027
Japan Society for the Promotion of ScienceKyoto Pharmaceutical University¥4.7M2023–2026
Japan Society for the Promotion of ScienceYamaguchi University¥3.9M2022–2026
HL-132: Increasing Adherence to Guideline-Based Exercise Therapy For Chronic Heart Failure
National Heart, Lung, and Blood InstituteUniversity of California, San Diego$752K2018–2023
Japan Society for the Promotion of ScienceTokoha University¥4.4M2021–2024
Neuro-Circulatory Function in Chronic Heart Failure
National Heart, Lung, and Blood InstituteUniversity of Nebraska Medical Center$1.6M1999–2022
Impact of interrupted cardiac rehabilitation in elderly chronic heart failure patients.
Japan Society for the Promotion of ScienceUniversity of Occupational and Environmental Health Japan¥3.9M2019–2025
Challenges to the Dilemma of Sarcopenia and Renal Dysfunction in Patients with Chronic Heart Failure
Japan Society for the Promotion of ScienceSt. Marianna University School of Medicine¥4M2017–2022
How this record changed
Summary written from the findings.